Literature DB >> 7339245

Steroid receptors in early breast cancer: value in prognosis.

R I Nicholson, F C Campbell, R W Blamey, C W Elston, D George, K Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7339245     DOI： 10.1016/0022-4731(81)90275-2

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN： 0022-4731            Impact factor:   4.292


× No keyword cloud information.
  15 in total

1.  An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.

Authors:  M R Williams; A Turkes; D Pearson; K Griffiths; R W Blamey
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

2.  Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.

Authors:  M Stierer; H Rosen; R Weber; H Hanak; J Spona; H Tüchler
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

3.  Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy.

Authors:  J F Robertson; A R Dixon; R I Nicholson; I O Ellis; C W Elston; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  Prognostic implication of estrogen receptor content in breast cancer.

Authors:  H O Adami; S Graffman; A Lindgren; J Sällström
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status.

Authors:  A F Howie; W R Miller; R A Hawkins; A R Hutchinson; G J Beckett
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

6.  Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes.

Authors:  R S du Toit; A P Locker; I O Ellis; C W Elston; R I Nicholson; R W Blamey
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

7.  Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.

Authors:  A R Dixon; J F Robertson; L Jackson; R I Nicholson; K J Walker; R W Blamey
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Objective measurement of therapeutic response in breast cancer using tumour markers.

Authors:  J F Robertson; D Pearson; M R Price; C Selby; R W Blamey; A Howell
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

9.  Quantitative aspects of the E2 receptor assay for human breast tumour cytosol using dextran-coated charcoal.

Authors:  D W Wilson; G Richards; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

10.  The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.

Authors:  J M Howat; M Harris; R Swindell; D M Barnes
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.